AIG
BIB icon

American International Group’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

American International Group’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-743
Closed -$30K – 3176
2016
Q1 		$30K Sell
743
-18,908
-96% -$836K ﹤0.01% 4126
2015
Q4 		$1.41M Sell
19,651
-63
-0.3% -$4.21K 0.01% 1270
2015
Q3 		$1.15M Buy
19,714
+19,242
+4,077% +$1.64M 0.01% 1359
2015
Q2 		$42.7K Sell
472
-1,004
-68% -$86.4K ﹤0.01% 4105
2015
Q1 		$117K Buy
1,476
+598
+68% +$44.4K ﹤0.01% 3438
2014
Q4 		$55.1K Buy
878
+288
+49% +$16.9K ﹤0.01% 3934
2014
Q3 		$30.7K Buy
+590
New +$28.6K ﹤0.01% 4184
2014
Q2 		– Sell
-22,122
Closed -$883K – 4963
2014
Q1 		$883K Buy
+22,122
New +$1M ﹤0.01% 1632
2013
Q4 		– Sell
-976
Closed -$31.8K – 4798
2013
Q3 		$31.8K Buy
976
+396
+68% +$11.5K ﹤0.01% 3913
2013
Q2 		$13.1K Buy
+580
New +$13.2K ﹤0.01% 4056

Other funds holding BIB

RIA
RPG Investment Advisory Pleasanton, California $829M AUM 36.68% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TH
Timber Hill Greenwich, Connecticut $15.4M AUM 30.7% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ICAS
Investors Capital Advisory Services Lynnfield, Massachusetts $521M AUM 1.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

American International Group's BIB Position: Q2 2016 in Review

American International Group sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2016, closing a stake of 743 shares — an estimated $30K sold.

American International Group first reported a position in BIB in Q2 2013 and held it in 10 quarters. The position peaked at $1.41M in Q4 2015. 31 funds tracked by Wall St. Rank hold BIB as of Q2 2016.

  • American International Group reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 743 ProShares Ultra NASDAQ Biotechnology shares in Q2 2016, an estimated $30K.
  • American International Group first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2013 and held it in 10 quarters.
  • American International Group's ProShares Ultra NASDAQ Biotechnology position peaked at $1.41M in Q4 2015.
  • 31 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.